ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,631.22
      0.28%
      US Tech 100
      19,849.60
      0.02%
      Dow Jones
      40,211.72
      0.53%
      Brent Oil
      83.695
      -0.76%
      Bitcoin
      63,236.44
      -2.49%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Canada
      5. TSX
      6. Dye and Durham Limited (DND)

      7. Dye and Durham Limited (DND) News

      DND

      Dye and Durham (DND)

      Dye and Durham Limited
      		Date:
      Sort by:
       Showing the most relevant articles for your search:TSX:DND
      DateTimeSourceHeadlineSymbolCompany
      07/17/20139:00AMPR Newswire (Canada)Notice of Cipher Pharmaceuticals Inc. Q2 2013 Conference CallTSX:DNDDye and Durham Limited
      06/20/20138:30AMMarketwired CanadaAtlantis Systems Corp. Awarded Twin Otter Support Tool Contract by Department of National DefenceTSX:DNDDye and Durham Limited
      06/17/20138:00AMMarketwired CanadaAtlantis Systems Corp. Awarded Contracts by Department of National DefenceTSX:DNDDye and Durham Limited
      05/03/20137:00AMPR Newswire (Canada)Cipher reports record financial results for Q1 2013TSX:DNDDye and Durham Limited
      04/29/20138:00AMPR Newswire (Canada)Cipher Pharmaceuticals completes Latin American distribution and supply agreement for extended-release tramadolTSX:DNDDye and Durham Limited
      04/15/20133:27PMPR Newswire (Canada)Notice of Cipher Pharmaceuticals Inc. Q1 2013 Conference Call and 2012 Annual and Special Meeting of ShareholdersTSX:DNDDye and Durham Limited
      03/01/20137:00AMPR Newswire (Canada)Cipher reports record financial results for 2012TSX:DNDDye and Durham Limited
      02/21/20139:00AMPR Newswire (Canada)Notice of Cipher Pharmaceuticals Inc. Q4 and Year-End 2012 Conference CallTSX:DNDDye and Durham Limited
      01/03/20139:00AMPR Newswire (Canada)Cipher Pharmaceuticals to present at Biotech Showcase™ 2013TSX:DNDDye and Durham Limited
      11/26/20128:48AMPR Newswire (Canada)L’OCRCVM permet la reprise de la négociation - DNDTSX:DNDDye and Durham Limited
      11/26/20128:47AMPR Newswire (Canada)IIROC Trade Resumption - DNDTSX:DNDDye and Durham Limited
      11/26/20128:30AMPR Newswire (Canada)Cipher's partner launches Absorica™ (isotretinoin) capsules in U.S. marketTSX:DNDDye and Durham Limited
      11/26/20128:30AMPR Newswire (US)Ranbaxy Launches Absorica™ (Isotretinoin) Capsules In The U.S. Healthcare MarketTSX:DNDDye and Durham Limited
      11/26/20128:19AMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - DNDTSX:DNDDye and Durham Limited
      11/26/20128:19AMPR Newswire (Canada)IIROC Trading Halt - DNDTSX:DNDDye and Durham Limited
      11/22/20124:22PMMarketwired CanadaAtlantis Systems Corp. Announces Teaming Agreement With CAETSX:DNDDye and Durham Limited
      11/20/20128:55AMPR Newswire (Canada)/C O R R E C T I O N from Source -- Cipher Pharmaceuticals Inc./TSX:DNDDye and Durham Limited
      11/20/20128:23AMPR Newswire (Canada)Cipher Pharmaceuticals Announces Health Canada Approval of CIP-IsotretinoinTSX:DNDDye and Durham Limited
      10/24/20127:00AMPR Newswire (Canada)Cipher Reports Strong Q3 2012 Financial ResultsTSX:DNDDye and Durham Limited
      08/07/20128:00AMPR Newswire (Canada)Cipher Expands Dermatology FranchiseTSX:DNDDye and Durham Limited
      07/31/201212:23PMPR Newswire (US)FDA Approves NDA Supported By MedAvante Central RatingsTSX:DNDDye and Durham Limited
      05/29/201210:06AMPR Newswire (US)Ranbaxy Announces U.S. FDA Approval of CIP-Isotretinoin NDATSX:DNDDye and Durham Limited
      05/28/20128:00AMPR Newswire (Canada)/R E P E A T -- Cipher Pharmaceuticals announces FDA approval of CIP-ISOTRETINOIN/TSX:DNDDye and Durham Limited
      05/28/20128:00AMPR Newswire (US)/R E P E A T -- Cipher Pharmaceuticals announces FDA approval of CIP-ISOTRETINOIN/TSX:DNDDye and Durham Limited
      05/27/201211:30PMPR Newswire (US)Cipher Pharmaceuticals announces FDA approval of CIP-ISOTRETINOINTSX:DNDDye and Durham Limited
      05/27/201211:30PMPR Newswire (Canada)Cipher Pharmaceuticals announces FDA approval of CIP-ISOTRETINOINTSX:DNDDye and Durham Limited
      05/04/20127:00AMPR Newswire (Canada)Cipher Reports Q1 2012 Financial ResultsTSX:DNDDye and Durham Limited
      04/22/201211:47AMPR Newswire (Canada)Notice of Cipher Pharmaceuticals Inc. Q1 2012 Conference Call and 2011 Annual Meeting of ShareholdersTSX:DNDDye and Durham Limited
      03/19/20128:30AMPR Newswire (Canada)Cipher announces launch of Durela(TM) in CanadaTSX:DNDDye and Durham Limited
      02/22/20127:00AMPR Newswire (Canada)Cipher Reports Fiscal 2011 Financial ResultsTSX:DNDDye and Durham Limited
       Showing the most relevant articles for your search:TSX:DND